Entera Bio received notice from The NASDAQ Stock Market on March 1, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market and the matter is now closed. To regain compliance with the Rule, the Company’s ordinary shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days, which was achieved on March 1st, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENTX:
- Entera Bio Ltd. Maintains Nasdaq Listing with Price Compliance
- Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Entera Bio Ltd. Files SEC Registration for Private Placement
- Entera Bio files to sell 16.5M ordinary shares for holders
- Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference